Company Overview of Signum Biosciences, Inc.
Signum Biosciences, Inc., a biotechnology company, develops small-molecule therapeutics to modulate signal transduction imbalances. It offers therapeutic agents for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. The company also provides Cognion, a coffee extract that contains high levels of SIG1012 for cognitive performance and mental acuity, cardio-protection, anti-diabetic, anti-cancer, and sports performance. Signum Biosciences, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.
7 Deer Park Drive
Monmouth Junction, NJ 08852
Founded in 2002
Key Executives for Signum Biosciences, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Signum Biosciences, Inc., please visit www.signumbiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.